Lemborexant + Etravirine Interaction
Contraindicatedinteraction on record
Description
Moderate CYP3A inducer that decreases lemborexant exposure, which may reduce DAYVIGO efficacy. Concomitant use should be avoided.
Mechanism
CYP3A induction
Source: NLP:lemborexant